Eyes, Ears, Nose and Throat Health, Respiratory Health and Related Formulations
Presents the pathophysiology of altered health states and their management including both pharmacological and non-pharmacological interventions. Specific conditions covered in this course include infectious diseases and conditions affecting the respiratory system, eyes, ears, nose and throat; as well as principles of immunisation. The course considers aspects of pharmacy practice including a systematic review of prescription and non-prescription medications and Complementary and Alternate Medicines, which will address the quality use of medicines in the management of these conditions.
The course builds on student's existing knowledge and understanding of the principles of physical pharmacy and provides students with an understanding of how these principles are applied to the preparation of eye, ear, nose, throat (EENT) and inhaled dosage formulations. The stability of these drug products and factors influencing the storage and shelf life of products is included in this course. In considering the formulation of EENT preparations, inhaled dosage formulations and sterile drug products, the clinical application of eye drops and inserts; ear drops; nasal sprays, drops and irrigations; throat sprays and lozenges as well as dry powder and aerosol formulations will be discussed and expanded upon in this course.
Pharmacokinetic and Pharmacodynamic considerations in conditions affecting the respiratory system and EENT health are covered.
Application of the knowledge developed in this course will be complemented by clinical skills training.
- Semester 1 - 2016
- Semester 1 - 2017
On successful completion of the course students will be able to:
1. Describe the pathophysiology and management (pharmacological and non-pharmacological) of respiratory conditions.
2. Describe the pathophysiology and management (pharmacological and non-pharmacological) of conditions affecting the eyes, ears, nose and throat.
3. Describe the pathophysiology and principles for the treatment of infectious diseases affecting the upper and lower respiratory tract.
4. Gain an understanding of the signs, symptoms and complications of common infections affecting the upper and lower respiratory tract, be aware of the pathogens involved, apply the relevant diagnostic tests and be aware of first and second line infective therapy as well as non-pharmacological approaches to the management of these infections.
5. Understand the role of immunisation programs in public health and to be able to counsel clients about the advantages and potential risks of immunisation.
6. Describe the quality use of medicines' issues surrounding these therapeutic agents in the treatment of these conditions and continue to develop clinical skills and communication skills in the therapeutic management of these conditions.
7. Develop skills in the appropriate use of non-prescription products and advice on non-pharmacological treatment options in the management of these conditions.
8. Identify the principles of drug stability and discuss pharmacy practice issues relating to storage of EENT and inhaled drug formulations including advanced cold chain management.
9. Describe the formulation and manufacture of sterile drug products including eye drops and inserts; ear drops; nasal sprays, drops and irrigations; throat sprays and lozenges, dry powder and aerosol inhalations.
10. Describe the role of pharmacodynamics and pharmacokinetic factors that need to be considered in conditions affecting the respiratory system.
1. This course will cover the pathophysiology, therapeutic management (pharmacological and non-pharmacological) and pharmacy practice issues in the management of:
- Respiratory conditions (including asthma and COPD).
- Conditions of the eyes, ear, nose and throat (including glaucoma and common ear conditions).
2. The pathophysiology and principles for the management of the following infectious diseases:
- Upper respiratory tract infections (sinusitis, otitis media, pharyngitis).
- Lower respiratory infections (bronchitis, pneumonia, chronic lung sepsis, tuberculosis).
3. The concept of minor illness and major disease will be discussed, including the use of prescription and non-prescription products, including Complementary and Alternate Medicines. Non-pharmacological approaches to the management of these conditions will also be discussed.
4. The course covers advanced concepts in formulation development and design of EENT and inhaled preparations including:
- Sterile products, aseptic technique, microbial contamination, spoilage and preservation, principles of sterilisation and storage considerations.
- Advanced cold chain management.
- Advanced dispensing and compounding skills in the preparation of EENT and inhaled dosage forms including eye drops and inserts; ear drops; nasal sprays, drops and irrigations; throat sprays and lozenges, dry powder and aerosol inhalations.
5. The course covers all pharmacokinetic/pharmacodynamic considerations for therapeutic agents used in the management of conditions affecting the respiratory system.
6. The role of health promotion and public health strategies, such as immunisation schedules will be discussed and the effectiveness of such programs for health care in a global and Australian context.
This course is only available to students enrolled in the Bachelor of Pharmacy (Honours) program. Pre-requisite - successful completion of PHAR1101 and PHAR1201
PHAR2204 Clinical Pharmacotherapy 1
Formal Examination: Written exam *
In Term Test: Mid Term Test
Quiz: Mini Test quizzes
* This assessment has a compulsory requirement.
In order to pass this course, each student must complete ALL of the following compulsory requirements:
Course Assessment Requirements:
- Formal Examination: Pass Requirement - Students must pass this assessment item to pass the course.
Face to Face On Campus 3 hour(s) per Week for 10 Weeks
Some lectures may be delivered online
Face to Face On Campus 2 hour(s) per Week for 8 Weeks